Chinese herbal extracts in the treatment of HIV related disease in vitro

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Scutellaria baicaleusis, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Coptis chineusis, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Ligusticum wallichii, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Illicium lanceolatum, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Isatis tinctoria, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Erycibe obtusifolia, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Acanthopanax graciliatylus, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Bostaurus domesticus, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.

A method of inhibiting in vitro HIV infection in human T lymphocyte cells and mononuclear phagocytic lineage cells infected with HIV comprising contacting said infected cells with a pharmaceutical preparation consisting essentially of an extract from Inula helenium, at a concentration of said extract which is effective to inhibit viral antigen expression in said HIV infected cells.